Akèy › Kadyomiopati › Minnesota
Etid klinik pou Kadyomiopati nan Minnesota
8 etid pou Kadyomiopati ap chèche patisipan nan sit nan Minnesota.
Vil nan Minnesota
Tèks ofisyèl etid la (Anglè)
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Rochester
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 16, 2026 · NCT07052903Clinical Course Of Disease In Participants With FA-CM
- Mayo Clinic, Rochester
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06865482Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Mayo Clinic - Rochester, Rochester
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
- Mayo Clinic, Rochester
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jun 30, 2026 · NCT07137338Mayo AVC Registry and Biobank
- Mayo Clinic, Rochester
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Apr 27, 2026 · NCT03049254A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation
- Mayo Clinic, Rochester
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT07308704MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Mayo Clinic, Rochester
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629Genetic Markers of Cardiovascular Disease in Epilepsy
- Mayo Clinic, Rochester
Ap rekriteEtid obsèvasyon
Laj 18 a 50 · Tout sèks · Mizajou Sep 8, 2025 · NCT02824822Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.